Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Androgen Deprivation Therapy With Enzalutamide on Bladder Cancer Chemoprevention

NCT02605863 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT02605863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02605863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Androgen Deprivation Therapy With Enzalutamide on Bladder Cancer Chemoprevention
Lead sponsor
University of Rochester
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2016
Completion date
February 28, 2018
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer